STLN Starling Oncology, Inc.

Fundamentals / CIK 0001799191 / USD
Other share classes on CIK 0001799191: DFPH STLNW TOI TOIIW

Starling Oncology, Inc. reported $620.4M in revenue and a net loss of $35.54M for the trailing twelve months ended September 30, 2026 (up 24.3% year over year), with a -3.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open STLN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$504.3M$252.1M$0-$120.4MFY 2020 Revenue: $187.5MFY 2020 Net Income: -$14.32M2020FY 2021 Revenue: $203.0MFY 2021 Net Income: -$10.93M2021FY 2022 Revenue: $252.5MFY 2022 Net Income: $152K2022FY 2023 Revenue: $324.2MFY 2023 Net Income: -$83.07M2023FY 2024 Revenue: $393.4MFY 2024 Net Income: -$64.66M2024FY 2025 Revenue: $502.7MFY 2025 Net Income: -$60.61M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $502.7M $393.4M $324.2M $252.5M $203.0M $187.5M
Selling, General & Admin $105.6M $107.8M $113.9M $119.7M $83.36M $41.90M
Operating Income -$36.08M -$60.12M -$77.02M -$81.95M -$45.86M -$8.20M
EBITDA -$29.14M -$53.83M -$71.14M -$77.54M -$42.52M -$5.02M
Interest Income -- -- -- -- -- $254K
Interest Expense $11.28M $7.50M $6.78M -- $320K $347K
Income Before Tax -$60.74M -$64.66M -$83.10M -$91K -$11.60M -$14.81M
Income Tax Expense -$131K $0 -$36K -$243K -$671K -$493K
Net Income -$60.61M -$64.66M -$83.07M $152K -$10.93M -$14.32M
Basic EPS -$0.54 -$0.71 -$0.92 $0.00 -$0.16 -$0.24
Diluted EPS -$0.54 -$0.71 -$0.92 -$0.21 -$0.16 -$0.24
Basic Shares Outstanding 92.4M 75.0M 73.7M 72.8M 66.2M 59.1M
Diluted Shares Outstanding 92.4M 75.0M 73.7M 80.6M 66.2M 59.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $169.8M $161.3M $147.4M $142.0M $136.6M $119.8M $104.4M $100.3M
Selling, General & Admin $32.13M $29.94M $28.21M $28.04M $25.25M $26.91M $25.38M $24.86M
Operating Income -$2.98M -$4.62M -$6.51M -$6.91M -$8.05M -$11.21M -$9.91M -$11.93M
EBITDA -$1.46M -$2.78M -$4.90M -$5.28M -$6.33M -$9.41M -$8.13M -$10.22M
Interest Expense $1.81M $1.86M $1.93M $4.80M $1.92M $1.87M $5.57M $1.17M
Income Before Tax -$15.75M -$9.79M -$2.49M -$7.51M -$16.50M -$17.14M -$19.59M -$13.18M
Income Tax Expense $0 $0 $0 $0 $0 -$131K $0 $0
Net Income -$15.75M -$9.79M -$2.49M -$7.51M -$16.50M -$17.01M -$19.59M -$13.18M
Basic EPS -$0.13 -$0.08 -$0.02 -- -$0.14 -$0.15 -$0.21 --
Diluted EPS -$0.13 -$0.08 -$0.02 -- -$0.14 -$0.15 -$0.21 --
Basic Shares Outstanding 104.7M 103.0M 101.8M -- 97.5M 93.2M 77.1M --
Diluted Shares Outstanding 104.7M 103.0M 101.8M -- 97.5M 93.2M 77.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents -- -- -- -- -- $900K $25K
Short-Term Investments -- $0 $49.37M $59.80M $0 -- --
Cash & Short-Term Investments -- -- -- -- -- $900K $25K
Accounts Receivable, Net $59.00M $48.34M $42.36M $39.82M $20.01M $17.15M --
Inventory $16.88M $10.04M $13.68M $9.26M $6.44M $4.35M --
Total Current Assets $112.7M $112.4M $143.5M $130.4M $154.1M $29.72M $25K
Property, Plant & Equipment, Net $10.68M $11.89M $10.88M $8.55M $4.19M $2.10M --
Goodwill $7.23M $7.23M $7.23M $21.42M $26.63M $14.23M --
Intangible Assets $11.02M $14.81M $17.90M $17.96M $18.25M $19.52M --
Long-Term Investments -- -- $0 $58.35M $0 -- --
Other Non-Current Assets $606K $589K $561K $477K $320K $122K --
Total Non-Current Assets $51.91M $60.30M $65.75M $131.2M $49.38M $35.97M $25K
Total Assets $164.7M $172.7M $209.2M $261.7M $203.4M $65.69M $50K
Accounts Payable $43.17M $24.32M $14.43M $9.37M $15.56M $12.64M --
Short-Term Debt -- -- -- $0 $183K $5.37M --
Deferred Revenue (Current) $2.28M $2.35M $545K $1.14M $262K -- --
Other Current Liabilities $20.64M $21.09M $14.00M $14.60M $13.92M $9.45M --
Total Current Liabilities $70.96M $52.22M $34.79M $29.72M $29.80M $28.61M $27K
Long-Term Debt $77.40M $93.13M $86.83M $80.62M $0 $6.56M --
Other Non-Current Liabilities $28K $125K $365K $868K $6.90M $807K --
Total Non-Current Liabilities $109.4M $116.9M $117.4M $108.8M $69.48M $8.98M $0
Total Liabilities $180.4M $169.1M $152.2M $138.5M $99.28M $37.59M $27K
Total Debt (incl. Leases) $103.8M $123.3M $119.8M $108.4M $183K $11.93M --
Common Stock $10K $8.0K $8.0K $7.0K $7.0K $6.0K --
Retained Earnings -$271.4M -$210.8M -$146.2M -$63.08M -$63.23M -$52.31M -$2.3K
Total Stockholders' Equity -$15.72M $3.59M $57.02M $123.2M $104.2M $28.10M $42.22M
Total Equity -$15.72M $3.59M $57.02M $123.2M $104.2M $28.10M $42.22M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Short-Term Investments -- -- -- -- -- -- -- $0
Accounts Receivable, Net $60.68M $66.35M $58.13M $59.00M $59.64M $55.66M $49.32M $48.34M
Inventory $36.63M $20.01M $24.29M $16.88M $18.88M $15.79M $12.31M $10.04M
Total Current Assets $137.7M $129.0M $116.9M $112.7M $110.1M $104.8M $106.8M $112.4M
Property, Plant & Equipment, Net $10.59M $10.58M $10.70M $10.68M $10.71M $10.85M $11.12M $11.89M
Goodwill $7.23M $7.23M $7.23M $7.23M $7.23M $7.23M $7.23M $7.23M
Intangible Assets $8.87M $9.59M $10.30M $11.02M $11.73M $12.45M $14.04M $14.81M
Other Non-Current Assets $1.42M $657K $620K $606K $586K $586K $591K $589K
Total Non-Current Assets $50.08M $49.24M $51.37M $51.91M $53.53M $55.01M $57.18M $60.30M
Total Assets $187.8M $178.2M $168.2M $164.7M $163.6M $159.8M $164.0M $172.7M
Accounts Payable $82.09M $60.28M $47.65M $43.17M $35.63M $34.93M $29.29M $24.32M
Deferred Revenue (Current) -- -- -- $2.28M $4.90M $5.20M $4.08M $2.35M
Other Current Liabilities $29.34M $27.43M $24.30M $20.64M $22.79M $22.89M $23.43M $21.09M
Total Current Liabilities $123.7M $94.94M $79.35M $70.96M $65.58M $64.78M $59.54M $52.22M
Long-Term Debt $72.52M $79.87M $78.61M $77.40M $76.19M $75.02M $73.89M $93.13M
Other Non-Current Liabilities $25K $30K $19K $28K $3.0K $10K $117K $125K
Total Non-Current Liabilities $101.4M $108.2M $105.2M $109.4M $110.3M $104.0M $99.39M $116.9M
Total Liabilities $225.1M $203.1M $184.5M $180.4M $175.9M $168.8M $158.9M $169.1M
Total Debt (incl. Leases) $97.77M $104.5M $104.9M $103.8M $103.6M $103.2M $102.4M $123.3M
Common Stock $10K $10K $10K $10K $10K $9.0K $9.0K $8.0K
Retained Earnings -$299.4M -$283.7M -$273.9M -$271.4M -$263.9M -$247.4M -$230.4M -$210.8M
Total Stockholders' Equity -$37.35M -$24.91M -$16.29M -$15.72M -$12.27M -$8.98M $5.07M $3.59M
Total Equity -$37.35M -$24.91M -$16.29M -$15.72M -$12.27M -$8.98M $5.07M $3.59M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$60.61M -$64.66M -$83.07M $152K -$10.93M -$441K
Depreciation & Amortization $6.94M $6.29M $5.87M $4.41M $3.34M $3.18M
Stock-Based Compensation $4.55M $11.15M $17.81M $27.68M $24.54M $151K
Change in Receivables -$12.31M -$5.97M -$4.56M -$20.29M -$2.19M -$6.76M
Change in Inventory -$6.84M $3.64M -$4.38M -$1.73M -$1.84M -$465K
Change in Payables $19.64M $9.21M $5.06M -$6.19M $2.92M $3.76M
Operating Cash Flow -$24.59M -$26.54M -$36.31M -$61.76M -$32.68M $508K
Capital Expenditure -$3.20M -$3.79M -$4.57M -$5.53M -$2.85M -$1.19M
Free Cash Flow -$27.79M -$30.33M -$40.88M -$67.28M -$35.53M -$686K
Acquisitions, Net -- $0 -$4.46M -$8.58M -$9.11M -$150K
Purchases of Investments -- $0 -$9.60M -$117.5M $0 --
Investing Cash Flow -$3.07M $46.21M $62.64M -$131.6M -$12.15M -$8.84M
Common Stock Issued $13.84M $0 $126K -- -- --
Share Repurchases -- $0 -$1.02M -$9.00M $0 --
Financing Cash Flow $11.56M -$3.49M -$6.85M $92.21M $154.0M $11.89M
Net Change in Cash -$16.10M $16.18M $19.48M -$101.2M $109.2M $3.55M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$15.75M -$9.79M -$2.49M -$7.51M -$16.50M -$17.01M -$19.59M -$13.18M
Depreciation & Amortization $1.52M $1.84M $1.62M $1.63M $1.72M $1.80M $1.78M $1.71M
Stock-Based Compensation $1.35M $1.07M $1.69M $1.32M $1.02M $752K $1.46M $1.29M
Change in Receivables $5.47M -$8.21M $864K $641K -$3.98M -$7.98M -$985K $6.17M
Change in Inventory -$16.62M $4.28M -$7.42M $2.01M -$3.10M -$3.48M -$2.27M $67K
Change in Payables $22.14M $12.50M $4.61M $7.71M $439K $6.43M $5.06M $739K
Operating Cash Flow $10.14M $11.94M -$2.21M $3.23M -$12.63M -$10.20M -$4.99M $4.00M
Capital Expenditure -$1.26M -$908K -$1.04M -$1.06M -$604K -$1.21M -$328K -$1.75M
Free Cash Flow $8.88M $11.03M -$3.26M $2.17M -$13.23M -$11.41M -$5.32M $2.25M
Purchases of Investments -- -- -- -- -- -- -- $0
Investing Cash Flow -$1.26M -$908K -$1.04M -$1.06M -$604K -$1.21M -$202K -$1.75M
Common Stock Issued -- -- -- $3.89M $7.61M $2.20M $137K $0
Financing Cash Flow -$13.08M -$218K -$28K $3.73M $10.60M $1.96M -$4.74M -$164K
Net Change in Cash -$4.20M $10.81M -$3.29M $5.91M -$2.63M -$9.45M -$9.93M $2.27M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -7.2% -15.3% -23.8% -32.5% -22.6% -4.4%
Net Profit Margin -12.1% -16.4% -25.6% 0.1% -5.4% -7.6%
Return on Equity (ROE) -- -1801.7% -145.7% 0.1% -10.5% -51.0%
Return on Assets (ROA) -36.8% -37.4% -39.7% 0.1% -5.4% -21.8%
Current Ratio 1.59x 2.15x 4.12x 4.39x 5.17x 1.04x
Quick Ratio 1.35x 1.96x 3.73x 4.08x 4.95x 0.89x
Debt to Equity -- 34.34x 2.10x 0.88x 0.00x 0.42x
Revenue Growth (YoY) +27.8% +21.3% +28.4% +24.4% +8.3% --
Net Income Growth (YoY) -- -- -54750.0% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -6533.1% --
5Y Revenue / Share Growth +71.6% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -3.4% -4.4% -6.0% -7.2% -8.9% -11.1% -12.9% -15.3%
Net Profit Margin -5.7% -6.2% -8.0% -12.1% -14.4% -15.5% -16.0% -16.4%
Return on Equity (ROE) -- -- -- -- -- -- -1269.7% -1801.7%
Return on Assets (ROA) -18.9% -20.4% -25.9% -36.8% -40.5% -41.2% -39.2% -37.4%
Current Ratio 1.11x 1.36x 1.47x 1.59x 1.68x 1.62x 1.79x 2.15x
Quick Ratio 0.82x 1.15x 1.17x 1.35x 1.39x 1.37x 1.59x 1.96x
Debt to Equity -- -- -- -- -- -- 20.20x 34.34x
Revenue Growth (YoY) +24.3% +34.6% +41.2% +41.6% +36.7% +21.5% +10.3% +16.9%
Operating Cash Flow Growth (YoY) -- -- -- -19.2% -1642.1% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -3.2% -1183.9% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001799191) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:35 UTC · Open in terminal